RYSTIGGO COLORS (DESIGN)

View On IC.GC.CA

REGISTERED

on 30 Sept 2024

Last Applicant/ Owned by

UCB BIOPHARMA SRL

Allée de la Recherche 60B-1070 Brussels,

Serial Number

2241889 filed on 24^th Feb 2023

Registration Number

TMA1260157 registered on 30^th Sept 2024

Registration expiry Date

30^th Sept 2034

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

H3B1S6

RYSTIGGO COLORS (DESIGN)

Trademark usage description

pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neu Read More

Vienna Information

24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

29 . 1 . 2

Yellow, goldJaune, or

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of neurological diseases, namely, myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for use in the treatment of immunological disorders

Classification kind code

Mark Details

Serial Number

2241889

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 30^th Sept 2024	Registration Pending
Submitted for opposition 55 on 30^th Sept 2024	Registered
Submitted for opposition 42 on 10^th Jul 2024	Advertised
Submitted for opposition 27 on 12^th Jun 2024	Approval Notice Sent
Submitted for opposition 26 on 12^th Jun 2024	Approved
Submitted for opposition 22 on 4^th Jun 2024	Search Recorded
Submitted for opposition 67 on 15^th Dec 2023	Agent Name Changed
Submitted for opposition 30 on 24^th Feb 2023	Filed
Submitted for opposition 1 on 24^th Feb 2023	Created
Submitted for opposition 31 on 24^th Feb 2023	Formalized